Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 |
filingDate |
2021-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2021-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2021-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-102342803-B1 |
titleOfInvention |
Novel pyrimidine derivatives and composition for preventing or treating neurodegenerative disease and cancer comprising thereof |
abstract |
The present invention relates to a novel pyrimidine derivative and a composition for preventing or treating neurodegenerative diseases and cancer comprising the same, wherein the pyrimidine derivative has excellent LRRK2 protein inhibitory activity and efficiently passes through the blood-brain barrier (BBB) Thus, it can be usefully used as a pharmaceutical composition for the prevention or treatment of neurodegenerative diseases and cancer. |
priorityDate |
2020-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |